Abstract
Abstract SY31-03: Employing TCRs in engineered T cells to develop therapeutic reagents for effectively targeting malignancies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1158/1538-7445.am2015-sy31-03
Copy DOIJournal: American Journal of Cancer | Publication Date: Aug 1, 2015 |
Abstract SY31-03: Employing TCRs in engineered T cells to develop therapeutic reagents for effectively targeting malignancies
Join us for a 30 min session where you can share your feedback and ask us any queries you have